Jiangxi Dongfu Pharmaceutical

Jiangxi Dongfu Pharmaceutical is a Chinese pharmaceutical company specializing in the development and manufacturing of small molecule drugs and active pharmaceutical ingredients (APIs). Based in Fuzhou, Jiangxi Province, the company produces a range of therapeutic products, including Tropisetron Citrate for the prevention of chemotherapy-induced nausea and vomiting, Bromhexine Hydrochloride for respiratory conditions, and Isosorbide Dinitrate for cardiovascular indications. The company operates GMP-certified manufacturing facilities and is part of the broader Huiyinbi Group, focusing on providing high-quality generic medications and optimized chemical synthesis processes. Jiangxi Dongfu Pharmaceutical is committed to enhancing drug stability and purity through innovative preparation methods, as evidenced by its patent portfolio in chemical synthesis.